Board of Directors

Patrick Daly | President & CEO

Mr. Daly has more than 25 years of experience in the medical device industry and has held leadership positions in sales, marketing, international marketing and positions of increasing responsibility throughout various Johnson & Johnson companies including Ethicon Endo-Surgery, Ethicon Products, J&J Medical Australia/New Zealand, and J&J Medical Asia Pacific.  Mr. Daly started Cohera Medical, Inc® in January 2006 and led successful funding rounds of over $125M in capital from private investors and private equity to facilitate Cohera Medical’s two lead products; TissuGlu® Surgical Adhesive and Sylys® Surgical Sealant through the FDA approval process for medical devices and commercialization in the U.S and EU.  Cohera has over 70 patents issued and pending, and Mr. Daly holds a patent for the surgical sealant technology.  Prior to starting Cohera Medical and his work at Johnson & Johnson, Mr. Daly spent over four years on active duty in the U.S. Army as a field artillery officer.  He is a graduate of the U.S. Military Academy at West Point where he received a Bachelor of Science Foreign Area Studies (Latin America). He played varsity lacrosse during his four years at West Point and was an All-American.  Mr. Daly currently represents the medical device industry by serving on the board of directors for AdvaMed (Advanced Medical Technology Association) as well as chairman of the Accel Board for smaller companies with revenue less than $100M.  His not for profit board membership includes The Johnny Mac Soldiers Fund (JMSF), (www.johnnymac.org) a 501(c)(3) non-profit committed to helping veterans and their families through education.

Ali J. Satvat | Director, Private Equity, Kohlberg Kravis Roberts & Co. L.P. (KKR)

Ali J. Satvat has served as a member of our Board of Directors since October 2015. Mr. Satvat is a Member of KKR and a senior leader of the Health Care industry team within KKR’s Americas Private Equity platform. Mr. Satvat has also served on the board of directors of several organizations, including Arbor Pharmaceuticals, Inc., Coherus BioSciences, Inc. and PRA Health Sciences, Inc. Prior to joining KKR, Mr. Satvat was a Principal with Apax Partners, where he invested in health care, served as a director of Chiron Holdings (Kinetic Concepts, Inc. and LifeCell Corporation) and TZ Holdings (The TriZetto Group, Inc.) and was actively involved with many of the firm’s successful growth investments. Previously, Mr. Satvat held various positions with Johnson & Johnson Development Corporation, Audax Group and The Blackstone Group, where he was involved in a broad range of transactions. Mr. Satvat holds an A.B. in History and Science from Harvard College and an M.B.A. in Health Care Management and Entrepreneurial Management from the Wharton School of the University of Pennsylvania. Mr. Satvat also serves on the board of directors of the Healthcare Private Equity Association.

Al Dombrowski

Mr. Dombrowski completed a successful 34-year career with Sears in 1994, serving in a variety of executive positions including National Business Manager for the Chicago Headquarters, Vice President for the U.S. Merchandise Group and Northeast U.S. Operations Manager. He has also been involved in a number of entrepreneurial ventures including Dawar, where he has been a board member since 1998 and Chairman since 2002. Mr. Dombrowski was Chief Operating Officer at Winner Steel Inc., as well as a board member at Pyramid Composites Inc., Vice Chairman at Guardian Personal Security Products and a Vice Chairman at Western Auto. He holds a B.S. in economics from Villanova University.

John C. Kern, Jr., J.D., M.B.A.

Mr. Kern is a founder and General Partner of Kern Whelan Capital. Prior to founding Kern Whelan, he spent over a decade building a successful track record in private equity investing as Managing Director of Reynolds, DeWitt & Co. in Cincinnati, where from 2001 he led all acquisitions and venture financings. Prior to joining Reynolds, DeWitt in 1997, Mr. Kern was with McKinsey & Company as a management consultant to manufacturing and financial services firms. He is on the board of directors of many companies, including Pallet Logistics of America, Dixon Midland Co., and ProService Hawaii, and serves as a member of the Industry Trade Advisory Committee on Services and Finance Industries, which is administered jointly by the US Department of Commerce and the US Trade Representative. Mr. Kern received a J.D. and M.B.A. from the University of Chicago and his B.A. from Princeton University. He serves on the board of the Bay Area Discovery Museum and as Vice President of the Ross School Foundation. Among Mr. Kern’s many charitable involvements in Cincinnati, he served as a Trustee of the Cincinnati Symphony, Trustee and development Chair of the Cincinnati Contemporary Arts Center, Trustee and Treasurer of The Taft Museum, and Trustee of the Visiting Nurse Association. He serves as President of his class at Phillips Exeter Academy and chaired his 25th reunion giving campaign.

Paul Thomas | Founder & CEO, Roka Bioscience

Mr. Thomas joined Roka Bioscience, a company focused on the development and commercialization of rapid, accurate and cost-effective molecular assays for biopharmaceutical processing, food safety and other industrial testing applications, as CEO and Founder in September 2009. Mr. Thomas previously served as Chairman, Chief Executive Officer and President of LifeCell Corporation, a publicly traded regenerative medicine company, from 1998 until it was acquired by KCI in 2008. Prior to joining LifeCell, Mr. Thomas held various senior positions during his tenure of 15 years with Ohmeda, a world leader in inhalation anesthetics and acute care pharmaceuticals. Mr. Thomas received his M.B.A. degree from Columbia University Graduate School of Business and completed his postgraduate studies in Chemistry at the University of Georgia Graduate School of Arts and Science. He received his B.S. degree in Chemistry from St. Michael’s College in Vermont. Mr. Thomas serves as a Director of AbioMed, Inc. (NASDAQ: ABMD) a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery; Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) focused on the commercialization of a life-altering therapy for debilitating and fatal orphan diseases and RTI Surgical®, a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.

Patrick Daly | President & CEO

Mr. Daly has more than 25 years of experience in the medical device industry and has held leadership positions in sales, marketing, international marketing and positions of increasing responsibility throughout various Johnson & Johnson companies including Ethicon Endo-Surgery, Ethicon Products, J&J Medical Australia/New Zealand, and J&J Medical Asia Pacific.  Mr. Daly started Cohera Medical, Inc® in January 2006 and led successful funding rounds of over $125M in capital from private investors and private equity to facilitate Cohera Medical’s two lead products; TissuGlu® Surgical Adhesive and Sylys® Surgical Sealant through the FDA approval process for medical devices and commercialization in the U.S and EU.  Cohera has over 70 patents issued and pending, and Mr. Daly holds a patent for the surgical sealant technology.  Prior to starting Cohera Medical and his work at Johnson & Johnson, Mr. Daly spent over four years on active duty in the U.S. Army as a field artillery officer.  He is a graduate of the U.S. Military Academy at West Point where he received a Bachelor of Science Foreign Area Studies (Latin America). He played varsity lacrosse during his four years at West Point and was an All-American.  Mr. Daly currently represents the medical device industry by serving on the board of directors for AdvaMed (Advanced Medical Technology Association) as well as chairman of the Accel Board for smaller companies with revenue less than $100M.  His not for profit board membership includes The Johnny Mac Soldiers Fund (JMSF), (www.johnnymac.org) a 501(c)(3) non-profit committed to helping veterans and their families through education.

Ali J. Satvat | Director, Private Equity, Kohlberg Kravis Roberts & Co. L.P. (KKR)

Ali J. Satvat has served as a member of our Board of Directors since October 2015. Mr. Satvat is a Member of KKR and a senior leader of the Health Care industry team within KKR’s Americas Private Equity platform. Mr. Satvat has also served on the board of directors of several organizations, including Arbor Pharmaceuticals, Inc., Coherus BioSciences, Inc. and PRA Health Sciences, Inc. Prior to joining KKR, Mr. Satvat was a Principal with Apax Partners, where he invested in health care, served as a director of Chiron Holdings (Kinetic Concepts, Inc. and LifeCell Corporation) and TZ Holdings (The TriZetto Group, Inc.) and was actively involved with many of the firm’s successful growth investments. Previously, Mr. Satvat held various positions with Johnson & Johnson Development Corporation, Audax Group and The Blackstone Group, where he was involved in a broad range of transactions. Mr. Satvat holds an A.B. in History and Science from Harvard College and an M.B.A. in Health Care Management and Entrepreneurial Management from the Wharton School of the University of Pennsylvania. Mr. Satvat also serves on the board of directors of the Healthcare Private Equity Association.

Al Dombrowski

Mr. Dombrowski completed a successful 34-year career with Sears in 1994, serving in a variety of executive positions including National Business Manager for the Chicago Headquarters, Vice President for the U.S. Merchandise Group and Northeast U.S. Operations Manager. He has also been involved in a number of entrepreneurial ventures including Dawar, where he has been a board member since 1998 and Chairman since 2002. Mr. Dombrowski was Chief Operating Officer at Winner Steel Inc., as well as a board member at Pyramid Composites Inc., Vice Chairman at Guardian Personal Security Products and a Vice Chairman at Western Auto. He holds a B.S. in economics from Villanova University.

John C. Kern, Jr., J.D., M.B.A.

Mr. Kern is a founder and General Partner of Kern Whelan Capital. Prior to founding Kern Whelan, he spent over a decade building a successful track record in private equity investing as Managing Director of Reynolds, DeWitt & Co. in Cincinnati, where from 2001 he led all acquisitions and venture financings. Prior to joining Reynolds, DeWitt in 1997, Mr. Kern was with McKinsey & Company as a management consultant to manufacturing and financial services firms. He is on the board of directors of many companies, including Pallet Logistics of America, Dixon Midland Co., and ProService Hawaii, and serves as a member of the Industry Trade Advisory Committee on Services and Finance Industries, which is administered jointly by the US Department of Commerce and the US Trade Representative. Mr. Kern received a J.D. and M.B.A. from the University of Chicago and his B.A. from Princeton University. He serves on the board of the Bay Area Discovery Museum and as Vice President of the Ross School Foundation. Among Mr. Kern’s many charitable involvements in Cincinnati, he served as a Trustee of the Cincinnati Symphony, Trustee and development Chair of the Cincinnati Contemporary Arts Center, Trustee and Treasurer of The Taft Museum, and Trustee of the Visiting Nurse Association. He serves as President of his class at Phillips Exeter Academy and chaired his 25th reunion giving campaign.

Paul Thomas | Founder & CEO, Roka Bioscience

Mr. Thomas joined Roka Bioscience, a company focused on the development and commercialization of rapid, accurate and cost-effective molecular assays for biopharmaceutical processing, food safety and other industrial testing applications, as CEO and Founder in September 2009. Mr. Thomas previously served as Chairman, Chief Executive Officer and President of LifeCell Corporation, a publicly traded regenerative medicine company, from 1998 until it was acquired by KCI in 2008. Prior to joining LifeCell, Mr. Thomas held various senior positions during his tenure of 15 years with Ohmeda, a world leader in inhalation anesthetics and acute care pharmaceuticals. Mr. Thomas received his M.B.A. degree from Columbia University Graduate School of Business and completed his postgraduate studies in Chemistry at the University of Georgia Graduate School of Arts and Science. He received his B.S. degree in Chemistry from St. Michael’s College in Vermont. Mr. Thomas serves as a Director of AbioMed, Inc. (NASDAQ: ABMD) a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery; Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) focused on the commercialization of a life-altering therapy for debilitating and fatal orphan diseases and RTI Surgical®, a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.

MKT-0007-EN REV J